Glycine vs Placebo for the Schizophrenia Prodrome
Glycine vs Placebo for the Schizophrenia Prodrome
Glycine is a natural amino acid neurotransmitter that acts as a co-agonist at NMDA receptors in brain. We hypothesize that symptoms of the schizophrenia prodrome will improve with glycine to a greater degree than with placebo.
A pilot clinical trial comparing glycine to placebo in patients with the schizophrenia prodrome.
Inclusion Criteria:
Exclusion Criteria: